NO994673L - Nye terapeutiske kombinasjoner av mirtazapin og antipsykotiske midler og anvendelse derav - Google Patents

Nye terapeutiske kombinasjoner av mirtazapin og antipsykotiske midler og anvendelse derav

Info

Publication number
NO994673L
NO994673L NO19994673A NO994673A NO994673L NO 994673 L NO994673 L NO 994673L NO 19994673 A NO19994673 A NO 19994673A NO 994673 A NO994673 A NO 994673A NO 994673 L NO994673 L NO 994673L
Authority
NO
Norway
Prior art keywords
mirtazapine
antipsychotics
new therapeutic
therapeutic combinations
combinations
Prior art date
Application number
NO19994673A
Other languages
English (en)
Other versions
NO994673D0 (no
Inventor
Christophorus Louis Broekkamp
Hermanus Henricus Ge Berendsen
Roger Martin Pinder
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Publication of NO994673D0 publication Critical patent/NO994673D0/no
Publication of NO994673L publication Critical patent/NO994673L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO19994673A 1997-03-27 1999-09-24 Nye terapeutiske kombinasjoner av mirtazapin og antipsykotiske midler og anvendelse derav NO994673L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP97200881 1997-03-27
EP97202785 1997-09-11
PCT/EP1998/001920 WO1998043646A1 (en) 1997-03-27 1998-03-25 New therapeutic combinations of mirtazapine and antipsychotic agents, for the treatment or prophylaxis of psychotic disorders

Publications (2)

Publication Number Publication Date
NO994673D0 NO994673D0 (no) 1999-09-24
NO994673L true NO994673L (no) 1999-11-17

Family

ID=26146283

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19994673A NO994673L (no) 1997-03-27 1999-09-24 Nye terapeutiske kombinasjoner av mirtazapin og antipsykotiske midler og anvendelse derav

Country Status (25)

Country Link
EP (1) EP0969845B1 (no)
JP (2) JP4377456B2 (no)
KR (1) KR100577865B1 (no)
CN (1) CN1226036C (no)
AR (1) AR012193A1 (no)
AT (1) ATE318604T1 (no)
AU (1) AU726194B2 (no)
BR (1) BR9808077A (no)
CA (1) CA2284551C (no)
CZ (1) CZ298105B6 (no)
DE (1) DE69833645T2 (no)
DK (1) DK0969845T3 (no)
ES (1) ES2259207T3 (no)
HK (1) HK1023293A1 (no)
HU (1) HUP0002742A3 (no)
ID (1) ID22283A (no)
IL (1) IL123716A (no)
NO (1) NO994673L (no)
NZ (1) NZ337618A (no)
PL (1) PL191449B1 (no)
PT (1) PT969845E (no)
RU (1) RU2222330C2 (no)
TR (1) TR199902334T2 (no)
TW (1) TW587938B (no)
WO (1) WO1998043646A1 (no)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL121076A (en) * 1996-06-19 2000-10-31 Akzo Nobel Nv Pharmaceutical combinations comprising mirtazapine and one or more selective serotonin reuptake inhibitors
US6280763B1 (en) 1999-05-10 2001-08-28 Pierce Management, Llc Apparatus and method for transdermal delivery of bupropion
FR2797399B1 (fr) * 1999-08-13 2002-10-18 Aventis Pharma Sa Utilisation de la cyamemazine dans le traitement du sevrage aux benzodiazepines
FR2802101B1 (fr) 1999-12-10 2003-02-28 Aventis Pharma Sa Association de cymemazine et d'un neuroleptique atypique
US6350773B1 (en) 1999-12-10 2002-02-26 American Home Products Corporation Therapeutic combinations of (S)-2-(benzylamino-methyl)-2,3,8,9,-tetrahydro 7H-1,4-dioxino{2,3-e}indol-8-one and neuroleptics for the treatment or prevention of psychotic disorders
RU2268725C2 (ru) * 2000-01-19 2006-01-27 Акцо Нобель Н.В. Комбинация лекарственных препаратов, включающая миртазапин, для лечения депрессии и связанных расстройств
US6495154B1 (en) * 2000-11-21 2002-12-17 Vivus Inc. On demand administration of clomipramine and salts thereof to treat premature ejaculation
EP1795199A3 (en) * 2001-02-06 2007-07-25 AstraZeneca AB Quetiapine for the treatment of substance dependence or substance abuse
ATE360425T1 (de) 2001-02-06 2007-05-15 Astrazeneca Ab Verwendung von quetiapin für die behandlung von kokain-abhängigkeit
JP5547865B2 (ja) 2003-10-29 2014-07-16 ワイス・エルエルシー アプリンドルおよびその誘導体を含む持続放出型医薬組成物
PT1541197E (pt) * 2003-12-02 2009-06-04 Pharmaneuroboost N V Utilização de pipamperona e de um sndri, snri ou ssri para o tratamento de patologias do temperamento ou da ansiedade
US7884096B2 (en) 2003-12-02 2011-02-08 Pharmaneuroboost N.V. Method of treating mental disorders using of D4 and 5-HT2A antagonists, inverse agonists or partial agonists
EP1547650A1 (en) * 2003-12-02 2005-06-29 B & B Beheer NV Use of D4 and 5-HT2A antagonists, inverse agonists or partial agonists
US7855195B2 (en) 2003-12-02 2010-12-21 Pharmaneuroboost N.V. Method of treating mental disorders using D4 and 5-HT2A antagonists, inverse agonists or partial agonists
WO2005053796A1 (en) * 2003-12-02 2005-06-16 B & B Beheer Nv Use of d4 and 5-ht2a antagonists, inverse agonists or partial agonists
WO2005117916A1 (en) 2004-06-03 2005-12-15 F. Hoffmann-La Roche Ag Treatment with cisplatin and an egfr-inhibitor
AU2007255724B2 (en) * 2006-06-09 2012-05-10 Dainippon Sumitomo Pharma Co., Ltd. Novel tape preparation
JOP20120083B1 (ar) * 2011-04-05 2021-08-17 Otsuka Pharma Co Ltd توليفات تشتمل على بريكس ببرازول أو ملح منه وعقار ثاني للاستخدام في علاج اضطراب cns
DE102012011839B4 (de) 2012-06-14 2018-03-22 Norbert Müller Verwendung von Interferon-gamma in einem Verfahren zur Behandlung von psychiatrischen Erkrankungen
RU2509560C1 (ru) * 2013-03-22 2014-03-20 Общество С Ограниченной Ответственностью "Валента-Интеллект" Новые терапевтические комбинации миртазапина для применения при болевых расстройствах

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2410821A1 (de) * 1974-03-07 1975-09-18 Hoechst Ag Pharmazeutische kombinationspraeparate mit psychotroper wirkung und verfahren zu ihrer herstellung
CA1327008C (en) * 1988-01-15 1994-02-15 Walter Merz Anti-psychotic imidazobenzodiazepine
EP0431663B1 (en) * 1989-12-06 1994-01-12 Akzo Nobel N.V. Stabilized solutions of psychotropic agents
ZA935078B (en) * 1992-07-15 1994-02-07 Nicolaas Johannes Jaco Loetter Pharmaceutical composition
EP0669128B1 (en) * 1992-11-17 2000-01-05 Yoshitomi Pharmaceutical Industries, Ltd. Sustained-release microsphere containing antipsychotic and process for producing the same
JPH07242669A (ja) * 1994-03-07 1995-09-19 Akikazu Ogawa 四環系とブチロフェノン誘導体を化学結合した化合物

Also Published As

Publication number Publication date
NZ337618A (en) 2000-06-23
HUP0002742A3 (en) 2003-03-28
PL191449B1 (pl) 2006-05-31
ATE318604T1 (de) 2006-03-15
DE69833645D1 (de) 2006-04-27
EP0969845A1 (en) 2000-01-12
BR9808077A (pt) 2000-03-08
EP0969845B1 (en) 2006-03-01
TR199902334T2 (xx) 2000-01-21
CA2284551C (en) 2007-06-12
PL335890A1 (en) 2000-05-22
HK1023293A1 (en) 2000-09-08
NO994673D0 (no) 1999-09-24
JP2001521497A (ja) 2001-11-06
TW587938B (en) 2004-05-21
RU2222330C2 (ru) 2004-01-27
ID22283A (id) 1999-09-30
WO1998043646A1 (en) 1998-10-08
DK0969845T3 (da) 2006-06-19
AU7213998A (en) 1998-10-22
KR20010005677A (ko) 2001-01-15
CZ298105B6 (cs) 2007-06-27
JP5023315B2 (ja) 2012-09-12
AU726194B2 (en) 2000-11-02
HUP0002742A2 (hu) 2001-05-28
CN1251526A (zh) 2000-04-26
JP4377456B2 (ja) 2009-12-02
DE69833645T2 (de) 2006-08-24
CN1226036C (zh) 2005-11-09
KR100577865B1 (ko) 2006-05-10
CZ343199A3 (cs) 2000-04-12
IL123716A (en) 2001-03-19
ES2259207T3 (es) 2006-09-16
AR012193A1 (es) 2000-09-27
CA2284551A1 (en) 1998-10-08
JP2009280596A (ja) 2009-12-03
IL123716A0 (en) 1998-12-06
PT969845E (pt) 2006-05-31

Similar Documents

Publication Publication Date Title
NO994673L (no) Nye terapeutiske kombinasjoner av mirtazapin og antipsykotiske midler og anvendelse derav
NO20014560D0 (no) Quinasoliner og terapautisk anvendelse derav
NO20001045D0 (no) Nye cycliske tetrapeptidderivater og medisinsk anvendelse derav
NO20022289L (no) Ny anvendelse og nye N-azabisykloamidderivater
NO992297D0 (no) FremgangsmÕte og nye forbindelser
NO953991D0 (no) Ultrasomisk og elektro-kirurgisk håndstykke av piezotype
NO20001962D0 (no) Terapeutisk anvendelse av kinolinderivater
NO996433D0 (no) Nye formuleringer av legemidler, fremgangsmåter for fremstilling derav og fremgangsmåter for anvendelse derav
NO992770D0 (no) Nye heterocyklisk substituerte benzamider og deres anvendelse ved bekjempelse av sykdommer
NO954239D0 (no) Heterocykliske forbindelser og deres fremstilling og anvendelse
NO972125D0 (no) Hemmoroideblandinger og fremgangsmåte for anvendelse
NO975439D0 (no) Ketonderivater og medisinsk anvendelse derav
ID18679A (id) Penggunaan terapi lanjutan
NO992676D0 (no) 1,4-diazabicyklo[2,2,2]okt-2-ylmetylderivater, deres fremstilling og terapeutiske anvendelse
NO20035332D0 (no) Nye heterocykliske derivater og medisinsk anvendelse derav
NO962477D0 (no) Benzamidderivater, deres fremstilling og deres terapautiske anvendelse
NO974750D0 (no) Peptidatagonister av cellulær mitogenese og motogenese og deres terapautiske anvendelse
NO20012738D0 (no) Terapeutiske produkter og anvendelse derav
DK0835254T3 (da) Oxazolidinonderivater, deres fremstilling og deres terapeutiske anvendelse
NO984624D0 (no) Nye furan-diarylmetyliden-derivater, fremgangsmÕte for deres fremstilling og terapeutiske anvendelser derav
NO20030547D0 (no) Azabicykliske derivater og deres terapeutiske anvendelse
NO982696D0 (no) Anvendelse av tricykliske derivater av 1,4-dihydro-1,4-diokso-1H-naftalen, nye oppnÕdde forbindelser og deres applikasjon i terapi
NO964330L (no) Farmasöytisk sammensetning for terapeutisk behandling av tardiv dyskinesi og anvendelse derav
NO971424D0 (no) Nye heterocyklisk substituerte imidazolo-kinoksalidoner, deres fremstilling og anvendelse
NO20003128D0 (no) Nye p-aminofenylderivater og deres anvendelse

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application
FC2A Withdrawal, rejection or dismissal of laid open patent application